Literature DB >> 22918682

Readressing the role of Toll-like receptor-4 alleles in inflammatory bowel disease: colitis, smoking, and seroreactivity.

Anastassios C Manolakis1, Andreas N Kapsoritakis, Anastasia Kapsoritaki, Elisavet K Tiaka, Konstantinos A Oikonomou, Vassilis Lotis, Dimitra Vamvakopoulou, Ioanna Davidi, Nikolaos Vamvakopoulos, Spyros P Potamianos.   

Abstract

BACKGROUND: Toll-like receptor (TLR) polymorphisms, and especially TLR-4 Asp299Gly and TLR-4 Thr399Ile, have been linked with Crohn's disease (CD) and to a lesser extent with ulcerative colitis (UC), CD behavior, and compromised seroreactivity to microbial antigens. Available data, however, are conflicting. AIMS: To address these issues, the distribution of TLR-4 polymorphic alleles was assessed in patients with UC, CD, and healthy controls (HC), considering patient and disease characteristics as well as related serological markers.
METHODS: TLR-4 Asp299Gly and TLR-4 Thr399Ile polymorphisms were determined in 187 UC and 163 CD patients and 274 randomly selected HC. C reactive protein, anti-Saccharomyces cerevisiae mannan antibodies, anti-mannobioside carbohydrate antibodies, anti-laminariobioside carbohydrate antibodies IgG, and anti-chitobioside carbohydrate antibodies (ACCA) IgA levels were also assessed.
RESULTS: UC and especially pancolitis patients carried the mutant alleles more frequently compared to CD patients and HC or UC patients with different disease extents (P = 0.002 and P < 0.0001, respectively). Involvement of the colon was more frequent in CD patients with mutant TLR-4 compared to those with wild-type alleles (P = 0.004). Levels and positivity rates of ACCA IgA were lower in inflammatory bowel disease (IBD) patients carrying the mutant compared to those with wild-type alleles (0.075 < P < 0.05). Despite the mutant TLR-4 predisposition for UC pancolitis, smoking was associated with more limited disease (P < 0.001).
CONCLUSIONS: The presence of TLR-4 Asp299Gly and TLR-4 Thr399Ile polymorphisms is related to UC pancolitis, involvement of the colon in CD, and lower ACCA IgA levels. Smoking reduces the extent of UC, even in the presence of mutant alleles.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918682     DOI: 10.1007/s10620-012-2348-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  52 in total

1.  Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy.

Authors:  Walter Fries; Maria C Renda; Maria A Lo Presti; Antonella Raso; Ambrogio Orlando; Lorenzo Oliva; Maria R Giofré; Aurelio Maggio; Anna Mattaliano; Alfredo Macaluso; Mario Cottone
Journal:  Am J Gastroenterol       Date:  2005-12       Impact factor: 10.864

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

Review 3.  TLR4 signalling in the intestine in health and disease.

Authors:  M Fukata; M T Abreu
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

4.  Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.

Authors:  Masayuki Fukata; Kathrin S Michelsen; Rajaraman Eri; Lisa S Thomas; Bing Hu; Katie Lukasek; Cynthia C Nast; Juan Lechago; Ruliang Xu; Yoshikazu Naiki; Antoine Soliman; Moshe Arditi; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-05       Impact factor: 4.052

5.  Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.

Authors:  Masayuki Fukata; Anli Chen; Arielle Klepper; Suneeta Krishnareddy; Arunan S Vamadevan; Lisa S Thomas; Ruliang Xu; Hiroyasu Inoue; Moshe Arditi; Andrew J Dannenberg; Maria T Abreu
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

6.  The Toll-like receptor 4 D299G and T399I polymorphisms are associated with Crohn's disease and ulcerative colitis: a meta-analysis.

Authors:  Xiuyun Shen; Ruihua Shi; Hongjie Zhang; Kebei Li; Yang Zhao; Ruyang Zhang
Journal:  Digestion       Date:  2010-01-09       Impact factor: 3.216

Review 7.  Functional consequences of toll-like receptor 4 polymorphisms.

Authors:  Bart Ferwerda; Matthew Bb McCall; Karlijn Verheijen; Bart-Jan Kullberg; André Jam van der Ven; Jos Wm Van der Meer; Mihai G Netea
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

8.  Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis.

Authors:  Helga-Paula Török; Jürgen Glas; Laurian Tonenchi; Thomas Mussack; Christian Folwaczny
Journal:  Clin Immunol       Date:  2004-07       Impact factor: 3.969

9.  Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.

Authors:  Peter Laszlo Lakatos; Istvan Altorjay; Tamas Szamosi; Karoly Palatka; Zsuzsanna Vitalis; Judit Tumpek; Sandor Sipka; Miklos Udvardy; Tamas Dinya; Laszlo Lakatos; Agota Kovacs; Tamas Molnar; Zsolt Tulassay; Pal Miheller; Zsolt Barta; Winfried Stocker; Janos Papp; Gabor Veres; Maria Papp
Journal:  Inflamm Bowel Dis       Date:  2009-03       Impact factor: 5.325

10.  Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis.

Authors:  Lenka Frolova; Pavel Drastich; Pavel Rossmann; Klara Klimesova; Helena Tlaskalova-Hogenova
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

View more
  7 in total

Review 1.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

2.  Impact of probiotics on toll-like receptor 4 expression in an experimental model of ulcerative colitis.

Authors:  Xia Yang; Yu Fu; Jun Liu; Hong-Yu Ren
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-10-20

3.  Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis.

Authors:  Yang Cheng; Yun Zhu; Xiuping Huang; Wei Zhang; Zelong Han; Side Liu
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

4.  Follicular fluid oocyte/cumulus-free DNA concentrations as a potential biomolecular marker of embryo quality and IVF outcome.

Authors:  M Dimopoulou; G Anifandis; C I Messini; K Dafopoulos; S Kouris; S Sotiriou; M Satra; N Vamvakopoulos; I E Messinis
Journal:  Biomed Res Int       Date:  2014-06-15       Impact factor: 3.411

5.  Artesunate exerts protective effects against ulcerative colitis via suppressing Toll‑like receptor 4 and its downstream nuclear factor‑κB signaling pathways.

Authors:  Yu-Xuan Chen; Xiao-Qi Zhang; Cheng-Gong Yu; Shu-Ling Huang; Ying Xie; Xiao-Tan Dou; Wen-Jia Liu; Xiao-Ping Zou
Journal:  Mol Med Rep       Date:  2019-06-05       Impact factor: 2.952

6.  Association of TLR4 (896A/G and 1196C/T) Gene Polymorphisms with Asthma Risk: A Meta-Analysis.

Authors:  Shaojun Li; Xinming Xie; Yang Song; Haoxiang Jiang; Xiaojuan Wu; Xiaofan Su; Lan Yang; Manxiang Li
Journal:  Med Sci Monit       Date:  2015-11-20

7.  Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis.

Authors:  Nezha Senhaji; Brehima Diakité; Nadia Serbati; Younes Zaid; Wafaa Badre; Sellama Nadifi
Journal:  BMC Gastroenterol       Date:  2014-12-10       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.